KINSEY REEVES: Open Payments
NPI 1013502210 · PERRYSBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 65 payments from 12 companies in 2025. Trend: 2023 $43 · 2024 $438 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $508 |
| MERZ NORTH AMERICA, INC. | 4 | $207 |
| Otsuka America Pharmaceutical, Inc. | 6 | $132 |
| Janssen Pharmaceuticals, Inc | 4 | $85 |
| Axsome Therapeutics, Inc. | 5 | $80 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Lundbeck LLC | 1 | $27 |
| Neos Therapeutics, LP | 1 | $24 |
| Alkermes, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: VRAYLAR, Xeomin, REXULTI, SPRAVATO, Auvelity, Qelbree, Adzenys XR-ODT, ARISTADA.
Industry payments across OH — which companies pay providers there.
